This Man Just Lost $15 Billion in a Half Hour
In the history of sudden wealth loss, Li Hejun may have set a new record.
Li, who was China's richest man until this week, saw his fortune drop by as much as $15 billion in a half-hour as the stock in his company, Hanergy Thin Film Power Group, fell by nearly half. Trading in the shares was halted Wednesday and Li didn't attend the company's annual meeting.
While plenty of billionaires have seen their fortunes cut in half over time, few if any have seen $15 billion wiped out in a half-hour. Li's total fortune was around $30 billion before the stock plunged.
Prior to the drop, the company's shares had risen by more than fivefold since September, baffling analysts. Reuters reports that Hong Kong regulators are looking at alleged market manipulation with the stock.
Related: America’s Highest Paid CEO: It’s Not Who You Think
In a similar wealth decline, Hong Kong property and electronics magnate Pan Sutong has lost more than $11 billion this week as shares of two listed companies, Goldin Financial and Goldin Property, both closed down more than 40 percent.
Pan owns around 65 percent of Goldin Property and more than 70 percent of Goldin Financial, according to filings. His fortune was listed at more than $28 billion, making him Hong Kong's second-richest man.
That means that the two men have lost more in one day that the total net worth of Carl Icahn, Steve Ballmer or Michael Dell.
Pan is known for his large lifestyle. He's a big polo supporter and has sponsored a polo event in Britain attended by Princes William and Harry. He's said that the sport "is a way of life and belief in a sense of nobility."
Pan also owns vineyards around the world, including three in France and one in California's Napa Valley, called the Sloan Estate, which he purchased in 2011 for around $40 million.
This article originally appeared on CNBC
Read more from CNBC:
Playboy keeps it's clothes on
Kickstarter darling Pebble may be in a rough patch
McDonald's CEO: Ronald is here to stay
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
